We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

NIH Awards BellBrook Labs Phase II Grant to Develop HTS Assays

News   May 31, 2018 | Original story from Bellbrook Labs

 
NIH Awards BellBrook Labs Phase II Grant to Develop HTS Assays
 
 
Advertisement
 

RELATED ARTICLES

Could Heparin Be Used To Stop SARS-CoV-2 From Infecting Human Cells?

News

SARS-CoV-2 uses a surface spike protein to latch onto human cells and initiate infection. But, the drug heparin is capable of binding tightly to the same surface spike protein, potentially blocking the infection from happening.

READ MORE

RNA Editing for Rett Syndrome Takes a Step Forward

News

In a new study, a genomic error that causes Rett Syndrome was corrected in the brains of mice by rewriting the genetic instructions carried by the RNA.

READ MORE

Breast Cancer Cells Disrupt Local Immune Defenses

News

Cold Spring Harbor Laboratory (CSHL) Associate Professor Mikala Egeblad and her colleagues describe a newly understood way by which breast cancer cells sabotage a key player in the body’s immune system.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Drug Discovery Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE